Rederm Ointment, 30g
Category
Acne
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Russia
Package quantity, pcs
one
Rederm ointment tube 30g
Name ENG
REDERM
Clinical and pharmacological group
Drug with anti-inflammatory and keratolytic action for external use
ATX code
Betamethasone in combination with other drugs
Dosage
0.05% + 3% x 30g
Structure
100 g:
- betamethasone dipropionate in terms of betamethasone 0.05 g
- salicylic acid 3.0 g
excipients: liquid paraffin (liquid paraffin), petrolatum (white vaseline, white soft paraffin).
Indications
Drug with anti-inflammatory and keratolytic action for external use
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
INN / Active ingredient
Betamethasone, Salicylic acid
Specifications
Category
Acne
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
2 years old
Way of introduction
Outwardly
Vacation conditions
Without recipe
Brand name
Vertex
The amount of the dosage form in the primary package
30 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07XC01 Betamethasone, in combination with other drugs
Dosage form
Ointment for external use
The target audience
Adult
Expiration date in days
730
Package weight, g
45
Mode of application
:
Outwardly.
Apply to the affected areas from the calculation: a column of Rederm ointment 0.5 cm long on a skin area of about 7 cm × 7 cm, rubbing slightly, with a thin layer 2 times a day.
A different frequency of use can be established by a doctor, based on the severity of the disease.
In mild cases, it is sufficient to apply the ointment, as a rule, once a day
more severe lesions may require more frequent use.
If necessary, apply occlusive dressings, which are changed every 24 hours.
The duration of treatment depends on the effectiveness and tolerability of therapy and is 2-4 weeks.
If clinical improvement does not occur, the diagnosis must be clarified.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + keratolytic agent
Dosage (volume) of the substance in the preparation
:
betamethasone dipropionate in terms of betamethasone 0.05 g, salicylic acid 3.0 g